Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endogenous Candida endophthalmitis.

Ahmed Sallam1, William Lynn, Peter McCluskey

  • 1Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, City Road, London EC1V 2PD, UK. ahmedsallam11@yahoo.com

Expert Review of Anti-Infective Therapy
|October 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond the Usual: A Case Series on Atypical Manifestations of HLA-B27 Uveitis.

Ocular immunology and inflammation·2026
Same author

Deconstructing White Dot Syndromes-Multimodal Imaging in Uveitis (MUV) Taskforce: Report 11.

American journal of ophthalmology·2026
Same author

Deciphering the genetic basis of wheat germination under ZnO nano priming and drought stress through integrated QTL mapping and network analyses.

BMC plant biology·2026
Same author

Selective decreases in regulatory B cell (Breg) subsets in active uveitis: IL-10+CD19+CD24hiCD38hiBreg in patients and B10 Breg in mice.

International immunology·2026
Same author

Genome-wide association study and gene network analysis of drought tolerance in wheat during early growth.

Frontiers in plant science·2026
Same author

Quantitative trait loci associated with drought stress tolerance in wheat primed with zinc oxide nanoparticles at seed germination and seedling stages.

Scientific reports·2026
Same journal

Study of prescription-indication of antivirals for herpesviruses in a Colombian population: a cross-sectional study.

Expert review of anti-infective therapy·2026
Same journal

Effectiveness and safety of eravacycline-based regimens for resistant <i>Acinetobacter baumannii</i> infections: a systematic review and meta-analysis.

Expert review of anti-infective therapy·2026
Same journal

<i>Pneumocystis</i> pneumonia in non-HIV immunocompromised patients in 2026: evolving therapeutic standards.

Expert review of anti-infective therapy·2026
Same journal

Asymptomatic is not silent: proposal of HTLV-1-associated multiple inflammatory disease as an early neuroinflammatory state.

Expert review of anti-infective therapy·2026
Same journal

The endocarditis team: a review.

Expert review of anti-infective therapy·2026
Same journal

Synergistic antifungal effects and potential mode of action of crisaborole combined with azoles against drug-resistant <i>Candida albicans</i>.

Expert review of anti-infective therapy·2026
See all related articles

Intraocular Candida infections can cause vision loss. Early diagnosis and prompt treatment, including new antifungal agents, are crucial for managing Candida endophthalmitis and preserving sight.

Area of Science:

  • Ophthalmology
  • Mycology
  • Infectious Diseases

Background:

  • Intraocular Candida infections, including chorioretinitis and endophthalmitis, are uncommon but serious complications of systemic candidiasis.
  • These infections can lead to bilateral visual loss if not managed promptly.

Purpose of the Study:

  • To review the current literature on Candida endophthalmitis.
  • To discuss presentation, diagnosis, and management strategies.
  • To evaluate new systemic and intravitreal antifungal agents for intraocular fungal infections.

Main Methods:

  • Literature review of current studies on Candida endophthalmitis.
  • Analysis of diagnostic approaches and treatment modalities.
  • Assessment of emerging antifungal therapies.

Related Experiment Videos

Main Results:

  • Early diagnosis and prompt management significantly impact visual prognosis.
  • A range of systemic and intravitreal antifungal agents are available for treatment.
  • Newer agents offer improved efficacy and safety profiles.

Conclusions:

  • Candida endophthalmitis requires timely diagnosis and aggressive management.
  • Treatment strategies involve both systemic and local (intravitreal) antifungal administration.
  • Ongoing research into novel antifungal agents is vital for improving patient outcomes.